A multicenter randomised study comparing the efficacy of pegylated interferon-alfa-2a plus adevofir dipivoxil vs. pegylated interferon-alfa-2a plus placebo vs. adevofir dipivoxil for the treatment of chronic delta hepatitis: The hep-net/international delta hepatitis intervention trial (HID-IT)


Yurdaydin C., Wedemeyer H., Dalekos G., Erhardt A., Cakaloglu Y., Degertekin H., ...More

57th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases, Massachusetts, United States Of America, 27 - 31 October 2006, vol.44 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 44
  • City: Massachusetts
  • Country: United States Of America